Adam Raff

Adam Raff, M.D., Ph.D. currently serves as Senior Vice President of Clinical Development at Orbital Therapeutics since August 2025 and has been a Dermatologist at Beth Israel Deaconess Medical Center since May 2019. Additionally, Adam Raff holds an instructor position at Harvard Medical School since August 2016. Previously, Adam worked as Head of Clinical Development and Vice President, Head of Translational Medicine at Montai Therapeutics from November 2023 to August 2025 and as Vice President of Immunology at EQRx from September 2021 to September 2023, where responsibilities included overseeing clinical strategy for various immunology programs. Prior roles also include Senior Medical Director and Director of Translational Medicine at LEO Pharma and a Dermatologist at Massachusetts General Hospital. Academic achievements encompass a Post Doctoral Fellowship from Harvard Medical School - Massachusetts General Hospital and multiple degrees from Harvard University, Keck School of Medicine of the University of Southern California, and Georgetown University.